Profound Medical Corp (PROF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,741 | -28,669 | -19,142 | -14,145 | -8,215 |
| Depreciation Amortization | 283 | 1,604 | 1,348 | 976 | 479 |
| Accounts receivable | -600 | -1,424 | -1,235 | -212 | -365 |
| Other Working Capital | -550 | -5,629 | -4,724 | -1,855 | -1,020 |
| Other Operating Activity | 1,785 | 8,318 | 4,571 | 1,809 | 1,262 |
| Operating Cash Flow | $-5,823 | $-25,800 | $-19,182 | $-13,427 | $-7,859 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 7,273 | N/A | N/A | N/A |
| Debt Repayment | -206 | -44 | N/A | N/A | N/A |
| Common Stock Issued | 2,423 | 263 | 263 | 95 | 6 |
| Other Financing Activity | -73 | -461 | -240 | -161 | -81 |
| Financing Cash Flow | $2,144 | $7,031 | $23 | $-66 | $-75 |
| Exchange Rate Effect | 146 | -1,866 | -1,785 | -424 | 906 |
| Beginning Cash Position | 46,517 | 67,152 | 67,152 | 67,152 | 67,152 |
| End Cash Position | 42,984 | 46,517 | 46,208 | 53,235 | 60,124 |
| Net Cash Flow | $-3,533 | $-20,635 | $-20,944 | $-13,917 | $-7,028 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,823 | -25,800 | -19,182 | -13,427 | -7,859 |
| Free Cash Flow | -5,823 | -25,800 | -19,182 | -13,427 | -7,859 |